Daily median GH dose differed between the three groups (0.27 [0.04–1.26] vs. 0.31 [0.10–1.45] vs. 0.28 [0.10–0.83] mg in the NFPA, CD and acromegaly group, respectively, p < 0.001). This evidence concerns the gene GH1 and acromegaly.